| Financier | Commitments |
|---|---|
| International Bank for Reconstruction and Development | 400.00 |
| Borrower/Recipient | 934.00 |
Program Towards Elimination of Tuberculosis
Abstract*
The objective of the Program Towards Elimination of Tuberculosis Project is to improve the coverage and quality of TB control interventions in the private and public sector in targeted states of India. Growth has accelerated in the last two quarters to reach 8.2 percent in the first quarter of FY18-2019. This growth was supported by a revival in industrial activity, strong private consumption, and a rise in exports of goods and services. At the same... Show More
Development Objective
To improve the coverage and quality of TB control interventions in the private and public sector in targeted states of India
Key Details
Project Details
P167523
Active
Gyorgy Fritsche
Republic of India
September 25, 2018
(as of board presentation)
March 29, 2019
May 13, 2019
US$ 1334.00 million
Ministry of Health and Family Welfare
2019
US$ 400.00 million
N/A
June 27, 2024
March 31, 2025
No
BANK APPROVED
Finances
Financing Plan (US$ Millions)
Total Project Financing (US$ Millions)
| Product Line | IBRD/IDA |
|---|---|
| IBRD Commitment | 400.00 |
| IDA Commitment | N/A |
| IBRD + IDA Commitment | 400.00 |
| Lending Instrument | |
|---|---|
| Grant Amount | N/A |
| Total Project Cost** | 1334.00 |
Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025
No data available.
| Period | Financier | Transaction Type | Amount (US$) |
|---|---|---|---|
| Dec 15, 2021 | IBRD-89260 | Int Charges | 669,328.30 |
| Feb 25, 2022 | IBRD-89260 | Int Charges | 86,486.70 |
| Feb 25, 2022 | IBRD-89260 | Loan Repay | 10,067,157.00 |
| Feb 25, 2022 | IBRD-89260 | Loan Repay | 86,486.70 |
| Jun 15, 2022 | IBRD-89260 | Int Charges | 216,856.48 |
| Jun 15, 2022 | IBRD-89260 | Int Charges | 1,074,370.20 |
| Jun 15, 2023 | IBRD-89260 | Int Charges | 311,452.12 |
| Jun 15, 2023 | IBRD-89260 | Int Charges | 165,588.02 |
| Jun 15, 2023 | IBRD-89260 | Int Charges | 6,610,075.00 |
| Dec 15, 2022 | IBRD-89260 | Int Charges | 166,497.84 |
| Dec 15, 2022 | IBRD-89260 | Int Charges | 4,515,443.50 |
| Dec 15, 2023 | IBRD-89260 | Int Charges | 129,458.31 |
| Dec 15, 2023 | IBRD-89260 | Int Charges | 102,204.99 |
| Dec 15, 2023 | IBRD-89260 | Int Charges | 9,032,896.00 |
| Jun 27, 2023 | IBRD-89260 | Int Charges | 18,910.03 |
| Jun 27, 2023 | IBRD-89260 | Loan Repay | 4,971,074.00 |
| Jun 27, 2023 | IBRD-89260 | Loan Disb | 54,893,312.00 |
| Jun 15, 2024 | IBRD-89260 | Loan Repay | 1,959,691.10 |
| Jun 15, 2024 | IBRD-89260 | Int Charges | 57,555.24 |
| Jun 15, 2024 | IBRD-89260 | Int Charges | 97,451.11 |
| Jun 15, 2024 | IBRD-89260 | Int Charges | 9,684,104.00 |
| Mar 29, 2019 | IBRD-89260 | Loan Commitment | 400,000,000.00 |
| Dec 15, 2019 | IBRD-89260 | Int Charges | 303,349.30 |
| Dec 15, 2019 | IBRD-89260 | Int Charges | 9,815.00 |
| Jun 15, 2020 | IBRD-89260 | Int Charges | 458,986.22 |
| Jun 15, 2020 | IBRD-89260 | Int Charges | 431,648.34 |
| Aug 20, 2019 | IBRD-89260 | Loan Disb | 1,000,000.00 |
| Aug 20, 2019 | IBRD-89260 | Fee Charges | 1,000,000.00 |
| Jan 21, 2020 | IBRD-89260 | Loan Disb | 40,000,000.00 |
| Jun 15, 2021 | IBRD-89260 | Int Charges | 710,022.30 |
| Jun 15, 2021 | IBRD-89260 | Int Charges | 297,612.20 |
| Dec 15, 2020 | IBRD-89260 | Int Charges | 448,750.00 |
| Dec 15, 2020 | IBRD-89260 | Int Charges | 231,342.50 |
| Dec 18, 2020 | IBRD-89260 | Loan Disb | 122,204,584.00 |
| Dec 18, 2020 | IBRD-89260 | Loan Repay | 13,578,287.00 |
| Feb 25, 2022 | IBRD-89260 | Loan Disb | 103,961,072.00 |
| Dec 15, 2021 | IBRD-89260 | Int Charges | 296,805.22 |
Ratings
IMPLEMENTATION RATINGS
| Name | Review | Date |
|---|---|---|
| Progress towards achievement of PDO | Satisfactory | 2024-09-22 |
| Monitoring and Evaluation | Satisfactory | 2024-09-22 |
| Overall Implementation Progress (IP) | Moderately Satisfactory | 2024-09-22 |
COMPLETION RATINGS
No data available.
INDEPENDENT EVALUATION RATINGS
No data available.
Results Framework
PROJECT DEVELOPMENT OBJECTIVE INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
PDO Indicator 1- DLI 1.1: Number of private notifications, net of any decrease in public notifications in targeted states (Annual) Value 346919.00 677925.00 800000.00 Date May 29, 2020 May 20, 2024 June 30, 2024 Comment PDO Indicator 2- DLI 2.2: Proportion of TB patients receiving financial support via Nikshay Poshan Yojana in targeted states (Annual, by category of DBT scheme) Value 0.00 60.00 77.00 Date February 5, 2019 May 20, 2024 June 30, 2024 Comment PDO Indicator 2.1- DLI 2.2.1: Proportion of TB patients notified by public providers receiving 1st Nikshay Poshan Yojana payment intargeted states (Annual) Value 66.00 66.00 77.00 Date May 29, 2020 May 20, 2024 June 30, 2024 Comment PDO Indicator 2.2- DLI 2.2.2: Proportion of TB patients notified by private providers receiving 1st Nikshay Poshan Yojana payment in targeted states (Annual) Value 16.00 56.00 60.00 Date May 29, 2020 May 20, 2024 June 30, 2024 Comment PDO Indicator 3- DLI 3.1: Proportion of notified TB patients tested for Rifampicin susceptibility in targeted states (Annual) Value 30.40 81.70 64.00 Date May 29, 2020 May 20, 2024 June 30, 2024 Comment PDO Indicator 4-DLI 1.2: Treatment success rate of TB patients notified by private providers in targeted states (Annual, patients notified in prior calendar year) Value 55.00 86.00 80.00 Date May 29, 2020 May 20, 2024 June 30, 2024 Comment
INTERMEDIATE RESULTS INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Intermediate Results Indicator 15-DLI 4.2: Development and implementation of a performance-based management mechanism between the center and the targeted states Value N/A -Achieved all 9 project states have performance-ba Implementation in 8 States Date November 1, 2018 May 20, 2024 June 30, 2024 Comment Intermediate Results Indicator 4: GOI annual expenditure on strategic purchasing under NGO/Private Provider budget head in targetedstates (million INR per year) Value 197.00 316.70 760.00 Date November 1, 2018 May 20, 2024 June 30, 2024 Comment IRI 7: Proportion of TB patients notified by private providers for whom at least one DBT incentive payment was made to their private providers. (Reported data for TB patients disaggregated by gender) Value 0.00 76.00 60.00 Date November 1, 2018 May 20, 2024 June 30, 2024 Comment Intermediate Results Indicator 16: Number of targeted states adopted and transitioned from paper-based to electronic SOE generated from PFMS Value 0.00 9.00 9.00 Date November 1, 2018 May 20, 2024 June 30, 2024 Comment Intermediate Results Indicator 8: Proportion of beneficiaries receiving financial support (2nd payments of Nikshay Poshan Yojana) through DBT in targeted states Value 0.00 28.00 56.00 Date November 30, 2018 May 20, 2024 June 30, 2024 Comment 17: No. of Annual TB Forum at state & national level conducted to: (i) promote citizen engagement; (ii)foster learning within & between states; (iii)to provide a multisectoral platform for TB control Value 0.00 7.00 8.00 Date November 1, 2018 May 20, 2024 June 30, 2024 Comment Intermediate Result Indicator 9: Treatment success rate of female TB patients notified in targeted states in the private sector Value 0.00 86.00 60.00 Date November 30, 2018 May 20, 2024 June 30, 2024 Comment 18: Reduction of the staffing gap identified by the RNTCP Human Resource Plan for CTD and the Program States---service delivery staff Value 27.00 21.05 20.00 Date July 30, 2021 May 20, 2024 June 28, 2024 Comment 19: Reduction of the staffing gap identified by the RNTCP Human Resource Plan for CTD and the Program States---administrative staff Value 27.00 21.05 20.00 Date June 30, 2021 October 5, 2023 June 28, 2024 Comment Intermediate Results Indicator 1: Proportion of privately notified Pulmonary TB patients that have microbiological confirmation in targeted states Value 0.00 35.36 45.00 Date November 1, 2018 May 20, 2024 June 30, 2024 Comment Intermediate Results Indicator 10: Proportion of DRTB centers in the targeted states with the action plan for AIC Value 34.00 78.42 70.00 Date November 1, 2018 May 20, 2024 June 30, 2024 Comment Intermediate Results Indicator 5: Percentage of beneficiaries out of total notified TB Patients seeded in Nikshay within 3 months of notification. (a) Aadhaar Value 68.00 80.00 85.00 Date November 1, 2018 May 20, 2024 June 30, 2024 Comment 13: Annual surveillance system analysis published; including data quality by district, annual state/CTD surveillance system evaluation, and estimates for potential under-notification and duplication Value N/A Achieved Annual analysis published Date November 1, 2018 May 20, 2024 June 30, 2024 Comment Intermediate Results Indicator 2-DLI 1.3: Establishment of TSUs in CTD and targeted states to support activities related to privatesector, DBT, PFMS, and multi sectoral engagement as per agreed TOR Value No TSUs 1 NTSU and 9 STSUs have been established. N/A Date November 1, 2018 May 20, 2024 June 30, 2024 Comment Intermediate Results Indicator 11: Proportion of notified rifampicin-resistant TB cases with second-line drug-susceptibility testing results documented within 3 months of DR-TB treatment initiation Value 32.00 38.00 65.00 Date November 1, 2018 May 20, 2024 June 30, 2024 Comment Intermediate Results Indicator 5: Percentage of beneficiaries out of total notified TB Patients seeded in Nikshay within 3 months of notification. (b) Verified bank account Value 33.00 80.00 70.00 Date November 30, 2018 May 20, 2024 June 30, 2024 Comment Intermediate Results Indicator 14: Number of targeted states replacing paper TB registers with e-TB Nikshay adopted real-time monitoring of notification and quality of care in at least 50% ofdistricts Value 0.00 9.00 8.00 Date November 1, 2018 May 20, 2024 June 30, 2024 Comment Intermediate Results Indicator 3: Proportion of Blocks with molecular diagnostic services operational in targeted states Value 15.00 61.00 30.00 Date November 1, 2018 May 20, 2024 June 30, 2024 Comment Intermediate Results Indicator 12: Treatment success rate among MDR/RR-TB patients (treatment cohort) Value 46.00 68.00 65.00 Date November 1, 2018 May 20, 2024 June 30, 2024 Comment Intermediate Results Indicator 6: Gender responsive framework for RNTCP developed by CTD & approved by MOH&FW Value N/A Completed Framework developed & approved Date November 1, 2018 May 20, 2024 December 31, 2019 Comment